Inovio Pharmaceuticals, Inc.
Vaccines having an antigen and interleukin-21 as an adjuvant

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.

Status:
Grant
Type:

Utility

Filling date:

6 Nov 2018

Issue date:

18 May 2021